Background: Liver diseases are associated with significant morbidity and mortality. Punica granatum may have free radical scavenging activity and it can be used for the prevention and treatment of liver damage. Objective: To observe the hepatoprotective effects of Punica granatum on CCl 4 induced liver damage in rats. Methods: The experimental study was carried out in the Dept of Physiology, Dhaka Medical Ccollege, Dhaka from July 2013 to June 2014. For this purpose, 36 wistar albino rats were studied. After acclimatization for 7 days, they were divided into two groups-control and experimental group. Control group were subdivided into BC (Baseline control), CC (CCl 4 treated control) and SC (Silymarin treated control). Experimental group were subdivided into CP-APT (CCl 4 pretreated and aqueous extract of pomegranate treated), CP-EPT (CCl 4 pretreated and ethanolic extract of pomegranate treated) and APP-CT (Aqueous extract of pomegranate pretreated and CCl 4 treated). Each sub group consisted of 6 rats. All rats received basal diet for 8 days. In addition to basal diet on 8 th day, BC received single dose olive oil and CC received CCl 4 . Rats of SC received silymarin for 8consecutive days . In experimental groups, CP-APT received aqueous extract of Pomegranate and CP-EPT received ethanolic extract of Pomegranate for 8consecutive days. Moreover, APP-CT received aqueous extract of Pomegranate for 8 consecutive days and CCl 4 only on 8 th day. All rats were sacrificed on 9 th day and then blood samples were collected. Serum ALT and AST levels were estimated by using standard laboratory kits. Statistical analysis was done one way ANOVA and Bonferroni test. Results: The mean serum AST and ALT levels were significantly (p<0.001) higher in CC in comparison to those of BC. Serum AST and ALT levels of all experimental groups were significantly (P<0.001) lower than CC. Silymarin used as a standard reference also exhibited significant hepatoprotective activity against CCl 4 induced hepatotoxicity Conclusion: From the result of present study it can be concluded that, Pomegranate may have hepatoprotective effect by lowering ALT and AST levels.
Introduction
surveillance studies in the United States documented an annual incidence of newly diagnosed chronic liver disease of 72.3 per 100,000 populations. Over half (57%) of patients have hepatitis C viral infection, followed by alcohol induced liver disease (24%), non alcoholic fatty liver disease (9%), and hepatitis B viral infection (4%). Liver disease accounts for over 44,000 deaths per year in the United States (1.9% of all deaths), placing it as the eight leading cause of death 2 .
The principal causative factors for the liver diseases in developing countries are environmental toxins, parasitic disease, hepatitis B and C viruses, and hepatotoxic drugs and hepatotoxic agents (carbon tetrachloride ,thiocetamide) 3 . Carbon tetrachloride (CCl 4 ) is an industrial chemical that does not occur naturally. It can cause pathological lesions in treated animals that closely resemble the symptoms of cirrhosis in human, and so it is considered an excellent model to evaluate the efficacy of hepatoprotectants. CCl 4 induced hepatotoxicity depends on dose and duration of exposure 4, 5, 6 .
Pomegranate Linn. (Punicaceae), commonly known as pomegranate, recently described as nature's power fruit 7 . Pomegranate fruits are globally consumed as fresh fruit and in processed forms like juice, jam, wine, oil and also in extract supplements 8 . It is a rich source of polyphenolic compounds that include flavonoids and hydrolyzable tannins 9 . Pomegranate has been known to posses considerable pharmacological properties as pomegranate peel is a rich source of antioxidants, especially polyphenols. In some recent studies, pomegranate fruit and flower extracts exhibited free-radicals scavenging properties with simultaneous potent hepatoprotection against chemically induced liver damage in rodents 10, 11 .
Silymarin is a standardized extract of the milk thistle (Silybum marianum) which is used as a standard drug and exhibiting potent hepatoprotective activity at the dose range from 25-200 mg/kg in various experimental and clinical studies 12, 13 .
Liver diseases have become a worldwide problem and are associated with significant morbidity and mortality but its medical management is currently inadequate 14 . Therefore, there is a growing focus to evaluate scientific basis for the traditional herbal medicines that possess hepatoprotective effects 15 .Very few studies has been done yet to investigate the hepatoprotective effect of pomegranate.
With the above background, the present study was carried out to observe the hepatoprotective effects of Pomegranate in experimental animals after inducing hepatotoxicity by CCl 4 . Pomegranate extract preparation: Fruits of Pomegranate were washed and the peels were manually removed, cut into small pieces and then dried at room temperature for 2 days. Dried peels of Pomegranate were grinded in an electrical grinder which was subjected to drying overnight in an air-oven electrical dryer. Then the dried sample of Pomegranate was taken in the jar. After that, ethanol and water was poured into the jar in order to prepare alcoholic and aqueous extract of Pomegranate. Then, Pomegranate extract was filtered with fine cloth. By evaporating the solvent using a rotator evaporator under reduced pressure in water bath at a temperature of 60ºC. It was stored in freeze at around 4ºC and was fed to the experimental rats.
Methods
Before sacrifice, final body weights of all the rats were measured. On 9 th day all the animals were anaesthetized with the help of 30% chloroform and then sacrificed. The blood samples (approximately 5ml) were collected from the heart by directly puncturing with sterile disposable syringes and taken in separate clean and dry test tubes with proper identification numbers. Then blood was centrifuged at a rate of 4000 rpm for 5 minutes. After that the supernatant serum was separated from the blood, collected in a labeled eppendroff and preserved in a refrigerator at -20ºc until analytical measurement of serum for AST and ALT in Department of Pathology, DMC. Data was reported in Mean and ±SE. Statistical analyses were done by One-way ANOVA and Bonferroni test as applicable.
Results
Initial body weights of all rats were almost similar and showed no statistically significant difference of these values among the groups.
The final and % change of body weight was significantly (p<0.001) lower in group CC when compared to that of group BC, SC, CP-APT and CP-EPT. (Table I) .
In this study, the mean serum ALT and AST level were significantly (P<0.001) higher in CC in comparison to that of BC and SC. But these levels were significantly (p<0.001) lower in CP-APT, CP-EPT and APP-CT in comparison to that of CC. Again there was no significant difference in those levels between CP-APT and CP-EPT (Table II) .
Discussion
In the present study, the mean % change of body weight was significantly lower in CC in comparison to that of BC. This finding is similar with those of some researcher 16 . Again this level was significantly higher in experimental groups in comparison to that of CC. These findings are in consistent with those of some other researchers 17 .
In this study, significantly higher serum AST and ALT levels in CC in comparison to that of BC was observed. This finding was in agreement with other researchers 17, 18 . Again, mean serum AST and ALT levels were significantly lower in SC in comparison to that of CC. This finding is similar with those of some researcher 19 . However, no significant difference in ALT and AST was observed by some researchers 7 . This discrepancy may be due to the fact that in that study different extract of pomegranate was used. It has been suggested that most remarkable pathological characteristics of CCl 4 induced hepatotoxicity are fatty liver, cirrhosis and necrosis. These pathological lesions are due to formation of reactive intermediates such as trichloromethyl free radical (CCl 3 ) in the endoplasmic reticulum 20 . In the present study, hepatic damage was observed in CCl 4 treated rats as evidenced by an elevation of serum ALT and AST levels. Again, lower levels of serum ALT and AST observed in CP-APT, CP-EPT and APP-CT rats suggest that the possibility of Pomegranate extract to give protection against CCl 4 induced liver injury. Bodies of literature suggested that pomegranate has protective effect on liver damage due to its antioxidant properties. Antioxidant potential of pomegranate juice and peel, seeds extracts is attributed to their high polyphenolic content 21, 22 . Polyphenolic content has strong free radicals scavenging and antioxidant properties 23 . In this study effects both extracts of pomegranate are almost same. No significant difference was found between them. So both can be used as hepatoprotective. These hepatoprotective effects of pomegranate are most likely due to free radical scavenging activity. 22 However, the exact mechanism involved in the hepatoprotective activity of Pomegranate extract against CCl 4 induced liver damage in rats cannot be elucidated from the present study as concentration of free radicals was not assayed.
Conclusion
From the result of the study, it may be concluded that Pomegranate may have some hepatoprotective role against CCl 4 induced liver damage. 
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